LOADING
Comparing Salesforce Inc (CRM) and Pfizer Inc (PFE) across the Technology and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | CRM | PFE |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $161.7B | $160.0B |
| P/E Ratio | 24.2 | 36.9 |
| Forward P/E | 15.4 | 9.5 |
| PEG Ratio | 0.87 | 2.72 |
| EPS | $8.64 | $0.76 |
| Revenue Growth (YoY) | 13.3% | 2.6% |
| Profit Margin | 18.7% | 6.8% |
| Return on Equity | 16.9% | 5.0% |
| Dividend Yield | 0.82% | 6.19% |
| Beta | 1.15 | 0.28 |
| 52-Week High | $267.75 | $28.44 |
| 52-Week Low | $146.32 | $22.03 |
| Volume | -- | -- |
Salesforce Inc is the larger company by market capitalization. Salesforce Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Pfizer Inc offers a higher dividend yield for income investors. Salesforce Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.